Printer Friendly

Glaxo flu boost.

DRUGS giant GlaxoSmithKline should begin shipping a swine flu vaccine by September, as it revealed yesterday it was in discussions with more than 50 countries about its treatments.

The drug maker, which is one of several firms commissioned by the World Health Organisation (WHO) to produce a vaccine for the pandemic virus, said it had already agreed contracts for 195m doses with 16 countries worldwide.

The firm said it expected further "significant orders" of the H1N1 vaccine and announced plans to triple the availability of its swine flu treatment Relenza to 190m doses per year by the end of 2009.

In addition, Glaxo also has agreements worth pounds 152.3m to supply the US Government.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Daily Post (Liverpool, England)
Date:Jul 23, 2009
Previous Article:NS& I suffers biggest slump in history; In brief.
Next Article:FSA hits bank with pounds 3.2m fines.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters